Subscribed unsubscribe Subscribe Subscribe

Transparency Market Research

TMR is a market intelligence company providing global business research reports and consulting services.

Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

f:id:tmrreport:20140219163326j:plain

According to a new market report published by Transparency Market Research, "Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global NIPT market was valued at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019, to reach an estimated value of USD 3.62 billion in 2019.

The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers over the conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling (CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a non-invasive genetic screening test for the common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk pregnant women (above the age of 35 years). Owing to its ability to detect the presence of chromosomal abnormalities in fetuses of pregnant women as early as 9 to 10 weeks of gestation, the market for non-invasive prenatal testing market is witnessing a rapid increase in demand from all parts of the world.

MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest are the commercially available NIPTs in the market which are based on the direct analysis of cell-free fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of Sequenom, Inc.) accounted for the largest share (36.6%) of the global NIPT market in terms of revenue, owing to the fact that it was the first mover in the market place. During the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing market penetration by other aforementioned NIPTs such as Panorama and verify.

High incidence rate of babies born with certain type of chromosomal abnormalities, growing trend of child bearing at advanced maternal age and enhanced popularity of NIPT among gynecologists and high risk pregnant women are some of the major factors anticipated to drive growth of the NIPT market during the forecast period. Some of the most commonly detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau syndrome and monosomy X. On the other hand, ethical and regulatory hurdles are expected to pose significant challenges before the NIPT market to grow. Various professional committees across the world believe that the implementation of NIPT and the subsequent rise in uptake of prenatal testing is likely to increase the incidence of abortions. Therefore, professional groups such as The American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics and Gynecology have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.

Geographically, North America was the largest regional market in 2012 with a market share of 64.5% of the total revenue generated globally, followed by Europe. Almost every company operating in this market is adopting the same business model of marketing their tests via alliances with hospitals, diagnostic laboratories and physician offices. The increasing penetration by test developers in European, Asia-Pacific and Middle-East countries indicates promising growth in the near future in these markets. Sequenom, Inc., Verinata Health, Inc. (now a part of Illumina, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Health, LifeCodexx and Berry Genomics are the companies engaged in providing non-invasive prenatal tests worldwide.

 

The global non-invasive prenatal testing market is segmented as follows:

Non-Invasive Prenatal Testing Market, by Test

  •          MaterniT21 PLUS
  •          verifi
  •          Harmony
  •          Panorama
  •          NIFTY
  •          PrenaTest
  •          BambniTest

Non-Invasive Prenatal Testing Market, by Geography

  •          North America
  •          Europe
  •          Asia-Pacific
  •          Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Anti-aging Market is Expected to Reach USD 191.7 Billion Globally in 2019: Transparency Market Research

f:id:tmrreport:20140218205229j:plain

According to a new market report published by Transparency Market Research "Anti-aging Market (Anti-wrinkle products, Hair Color, Hair restoration treatment, Breast augmentation and Radio frequency devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global Anti-aging market was valued at USD 122.3 billion in 2013and is expected to grow at a CAGR of 7.8% from 2013 to 2019, to reach an estimated value of USD 191.7billion in 2019.

Aging is defined as cycles of biochemical activities in the body caused by factors which affect body over a period of time internally as well as externally and leads to degeneration of body affecting beauty, health and fitness of an individual. Anti-aging market has evolved over centuries and modern technology has contributed with widening its reach in products, services and devices. Anti-aging products provide a market which has high adoption as it is comparatively affordable and available than services and devices. Services market has been divided into the cosmetic surgeries and non-invasive treatments which involve certified medical practitioners, plastic surgeons and skilled beauticians. Services market for Anti-aging is expected to grow at CAGR of over 5% from 2013 to 2019.

Baby boomers (born 1946 -1964) a generation which was born in an era of inventions and revolutions are considered to be the most successful generation of 20th Century. Baby boomers are most potential drivers of anti-aging market as they are aging and getting more aware about the available anti-aging products, services and devices. In 2012, the first of the baby boomer generation reached near retirement age and it is estimated that for the next 18 years baby boomers will turn 65 at a rate of 8,000 individual per day. Anti-aging products market is considered to be the largest market in terms of revenue and it shows opportunity for new products which are safe and highly efficient. Anti-aging market is still evolving and contended with skepticism and incompatible clinical results related with the actual health and appearance benefits of many widely marketed products and services. The technological development and stringent regulations have helped this market to regain trust and belief of customers.

Asia-Pacific and Rest of the World (RoW) are expected to be the next potential destinations for anti aging market. China, South Korea, Japan and India are observed to be the most attractive destinations for cosmetic surgeries and governments of these countries and are promoting medical tourism for cosmetic surgeries which is believed to be one of the market drivers of these countries' anti-aging market. Brazil and Mexico are the major countries from RoW which are leading the anti-aging market. The developing economy of these regions and awareness about aging signs in men and women has made these regions as future attractive markets for anti-aging.

The Global Anti-aging market is segmented as follows:

Anti-aging Market, by Age demographics

  •          Baby boomers
  •          Generation X
  •          Generation Y

      Anti-aging Market, by Products

  •          UV absorbers
  •          Anti-Wrinkle Products
  •          Dermal Fillers
  •          Botox
  •          Anti-Stretch Mark Products
  •          Hair Color

      Anti-aging Market, by Services

  •          Anti-Pigmentation Therapy
  •          Anti-adult Acne Therapy
  •          Breast Augmentation
  •          Liposuction
  •          Abdominoblasty
  •          Breast Reduction
  •          Chemical Peel
  •          Eye Lid Surgery
  •          Hair Restoration Treatment
  •          Sclerotherapy

      Anti-aging Market, by Devices

  •          Anti-Cellulite Treatment Devices
  •          Microdermabrasion Devices
  •          Laser Aesthetics Devices
  •          Anti-aging Radio Frequency Devices

     Anti-aging Market, by Geography

  •          North America
  •          Europe
  •          Asia-Pacific
  •          Rest of the World (RoW)

      Browse more market research reports: Transparency Market Research

 

Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

f:id:tmrreport:20140211204000j:plain

According to a new market report published by Transparency Market Research, "Cord Blood Banking Services Market (Private and Public Cord Blood Banks) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", the global cord blood banking services market was valued at USD 12.40 billion in 2012 and is expected to grow at a CAGR of 5.6% from 2013 to 2019, to reach an estimated value of USD 15.23 billion in 2019.

 

Cord blood banking (CBB) is one of the fastest growing segments of the healthcare industry. Factors such as increasing awareness, initiatives taken by governments to regulate the CBB industry, an increasing number of diseases that can be treated using stem cell therapy and growing concerns about developing worldwide cord blood inventory will have an impact on the current model of the cord blood banking industry.

 

The global cord blood banking services market is segmented on the basis of type of service vendor and geography. Based on service vendor type the cord blood banking market is classified into private cord blood banks and public cord blood banks. The market share of private cord blood banks is larger than the public cord blood banks as private banks charge the service right from the collection of the cord blood followed by storage and processing charges, spends more on advertising and incentives as compared to public banks. It is expected that the global market for private banks will reach USD 11.58 billion in 2019 with the market growing at CAGR of 1.9% from 2013 to 2019. The shift from storing cord blood in private banks to public banks is growing the market share of public cord blood banks globally.

 

The United States, and some of the European countries such as the U.K. and Spain, are leading in cord blood banking services. Asian countries like China and India are emerging markets with higher population growth rate. UAE, Qatar and Saudi Arabia are some of the lucrative markets in RoW.

 

North America currently dominates the market but in future developing countries in Asia will lead the market. Growth drivers in the North American market are increasing awareness about the cord blood banking services, stem cell therapy and affordable cost.

 

Some of the key market players operating in this market include Cord Blood America, Inc., NeoStem, Inc., Cryo-Cell International, Inc., Cord Blood Registry Systems, Inc. and China Cord Blood Corporation.

 

The global cord blood banking services market is segmented as follows:

 

Based on Type of Service Vendor

  • Private cord blood banks
  • Public cord blood banks

Based on Geography

  • North America
  • United States
  • Canada
  • Europe
  • UK
  • Spain
  • France
  • Germany
  • Italy
  • Belgium
  • Asia-Pacific
  • India
  • China
  • Japan
  • Australia
  • New Zealand
  • Philippines
  • Rest of the World
  • Brazil
  • Argentina
  • Middle Eastern Countries
  • Russia

Browse more reports: Transparency Market Research

Equine Healthcare Market is Expected to Reach USD 24.5 Billion Globally in 2019: Transparency Market Research

f:id:tmrreport:20140210210954j:plain

According to a new market report published by Transparency Market Research "Equine Healthcare Market (Diagnostic Products, Therapeutic Products and Supplement Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global equine healthcare market was valued at USD 26.6 billion in 2012 and is expected to decline at a CAGR of -1.2% from 2013 to 2019, to reach an estimated value of USD 24.5 billion in 2019.

 

The equestrian industry results in a substantially high economic impact as a result of one of the industry's primary activity - horse racing and betting; horse racing and betting comprises ~20% share of the global betting/gambling market. The equestrian industry thus generates a multiplier effect resulting into turnover of over ~USD 500 billion per year. Due to the 'trickle-down effect' of flow of the economic impact of the overall equestrian industry, multiple support or secondary markets exist and sustain; the equine healthcare market is among such support or secondary markets. As the base of existence of the equestrian industry is the population/number of horses worldwide, any change in the equine population impacts the equestrian industry and the support or secondary markets such as the equine healthcare market. Many experts and corroborating statistical data reveals that the global equine population is expected to decline over the years till 2019; consequentially, the equine healthcare market too is expected to decline by 1.2% over six years, from 2013 to 2019, to reach an estimated value of USD 24,527.8 million in 2019.

 

Equine healthcare market comprises of various 'product market segments' in context of various products used for treatment of equine-specific healthcare conditions, diagnosis of equine-specific healthcare conditions and also supplements and protection products used for upkeep and maintenance of a horse. Thus the three prime segments of the equine healthcare market are equine diagnostic products, equine therapeutic products and equine supplement products.

 

In context of equine (pregnancy and gestation) diagnostic products, there are two key categories of products used namely UltraSound devices and equine urine test kits. Of the two categories, equine urine test kits are affordable and easy-to-use and interpret the results and also help overcome a prime limitation of UltraSound devices i.e. the kits are non-invasive in nature. Thus, we expect equine urine test kits to be increasingly preferred by the veterinarians and the end-users, going forward. Also, the equine urine test kit is a unique product to the equine species and cannot be substituted by the urine test kits for humans. Therefore, we estimate the urine test kits market to be a niche opportunity that is likely to be encashed by newer entrants thus expanding the market and driving growth of the equine diagnostic products market.

 

In terms of geographical markets of the equine healthcare market, the Asia-Pacific region is touted to be the 'next growth story'. A constituent of Asia-Pacific namely the Australian market is among the leading 'horse producing/breeding' countries. Additionally, China is expanding capacity and investing in horse racing and betting by importing quality breeds from other countries. China is thus intent on maintaining particularly race-horse breeds. As race-horses require additional and specific supplement and protection products, therapeutic and also diagnostic products, sales of all these products is thus expected to be high in the Asia-Pacific market. Therefore the afore-mentioned factors are likely to drive growth of the Asia-Pacific market.

 

The global equine healthcare market is segmented as follows:

 

Equine Diagnostic Products Market, by Type

  • Equine Pregnancy and Gestation Diagnostic Products Market
  • Equine Genotype Analysis Products Market

Equine Therapeutics Product Market, by Type

  • Equine Vaccines Market
  • Equine Antibacterials Market
  • Equine Antivirals Market
  • Equine Antiprotozoals/Dewormers Market
  • Equine Dopamine Agonists Market
  • Equine Anti-inflammatory Drugs Market
  • Equine Laxatives Market

Equine Supplement Products Market, by Type

  • Equine Performance Supplement Market
  • Equine Protection Products Market
  • Equine Prosthetics Market

Equine Healthcare Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World (RoW)

Browse more reports: Transparency Market Research

 

Surface Vision and Inspection Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

f:id:tmrreport:20140210182720j:plain

According to a new market report published by Transparency Market Research "Surface Vision and Inspection Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global market is expected to reach a value of USD 2.31 billion by 2019, at a CAGR of 8.9% from 2013 to 2019.

Due to increasing need of improving manufacturing production capacity and growing demand for international quality products from consumers, the demand for these systems is rising globally. In addition, shortage of skilled workers, increasing wages and manufacturing errors increases economic burdens on manufacturers. Owing to these, the global manufacturers are seeking for automated process utilization and quality management solutions to improve their sustainability in competitive environments. It also drastically reduces manufacturing errors and helps manufacturer to maintain consistent quality of product. In addition, it reduces production wastage and number of labors required in case of manual inspection. These are some factors which are expected to increase the demand of this market.

By components, surface vision and inspection cameras (SVIC) accounted for largest revenue share of 48.1% of the overall components market in 2012. Continuous advancement in micro-chips used in camera systems helps camera manufacturers to produce more smaller, reliable and cheaper cameras. In the last two decades manufacturers has shifted towards digital and smart cameras as they are more reliable and efficient than analog cameras. These advanced cameras provide better productivity and cost cut backs to manufacturers. Software and hardware components are expected to see the fastest growth due to growing demand for sophisticated software solutions that improves integration of surface vision and inspection systems with other factory automation products.

By type, computer based systems accounted for the largest revenue share of the overall surface vision and inspection market. These are cable of handling more complex operations at greater speed. In addition, these systems can be easily upgraded with advanced software and hardware as per requirements. This makes a computer based systems more customizable and preferred by many manufacturers over camera systems. However, demand of smart camera based systems is increasing among small and medium size manufacturers as it is cheaper and easily integrated with existing manufacturing facility. Moreover, camera based systems is expected to see the fastest growth with continuous development in smart cameras to handle complex applications.

While in case of application, semiconductor, automotive, electronics and electrical industries accounted for more than 60% of the overall surface vision and inspection market in 2012. Due to minute and ever needing testing applications of chips and fabricated systems, semiconductor manufacturing industry is expected to remain the largest end-use segment for surface vision and inspection systems. However, Demand of these systems is expected to increase rapidly in pharmaceutical, packaging and food industry. This is due to introduction of stricter manufacturing and inspection regulations globally.

By Geography, Asia-Pacific (APAC) accounted for 32.3% of the overall revenue share in 2012. This region is expected to maintain its dominating market share throughout the forecast period. This is due to estimated market of growing factory automation and other advanced automation industries in India, China, Taiwan, Australia, Thailand and many other emerging countries in this region.

Global surface vision and inspection industry comprises of large numbers of multinational and domestic components and end use product suppliers. The global surface vision and inspection industry is dominated by Cognex and accounted for 14.5% of the market share in 2012. Some other leading players in this industry include ISRA VISION, Edmund Inc, Adept Technology Inc, Edmund Optics Inc, Toshiba Teli Corp, Panasonic Corp, Matrox Imaging, Perceptron Inc and others.

The global surface vision and inspection market is segmented as below:

By Components

  • Camera
  • Optics
  • Lighting
  • Frame Grabbers
  • Software and Hardware

By Type

  • Computer Systems
  • Camera Systems

By Application

  • Automotive
  • Electrical/Electronics
  • Semiconductor
  • Medical
  • Pharmaceutical
  • Metal
  • Rubber and Plastics
  • Printing
  • Wood and Paper
  • Other Industrial Application (Glass and Non-Woven)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 Browse more reports: Transparency Market Research

 

Cardiac Prosthetic Devices Market is Expected to Reach USD5.3 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global cardiac prosthetic devices market was valued at USD 2,945.3million in 2012 and is estimated to reach a market worth USD  5,290.0million in 2019at a CAGR of 8.7% from 2013 to 2019.

Cardiac prosthetics are chronic alternatives that replace a damaged or diseased part in the body.Cardiac prosthetic devices are used in the treatment of blockages in heart valves. Implantation of these devices is being increasingly accepted as one of the common procedures due to a rise in the number of patients suffering from valvular diseases. Prosthetic valve thrombosis (PVT), prosthetic valve endocarditis (PVE), mechanical hemolytic anemia and thromboembolism are some of the complications that arise from failure of the primary valves.The growth of cardiac prosthetic devices market is primarily driven by increasing geriatric population, rise in the number of cardiac diseases (coronary artery, cardiovascular, peripheral vascular, rheumatic heart, cerebrovascular and valvular heart diseases). In addition, technological advances are also aiding the growth of this industry.

The cardiac prosthetic devices market can be segmented as heart valves and pacemaker. Heart valves are further categorized into mechanical heart valves, tissue heart valves and transcatheter heart valves. The market for cardiac prosthetic devices promises high growth mainly due to increasing incidence of cardiovascular disorders, rising preference for minimally-invasive procedures and consistent growth in the geriatric population. Additionally, a rise in obesity followed by continuous product modification and technological upgradation resulting in development of effective devices would propel the growth and uptake of cardiac prosthetic devices. However, high cost of devices, stringent approval process of these devices (Class III devices) and certain clauses of the Affordable Healthcare Act (AHA) that contribute in overall increase of the cost of medical devices are some of the factors that might hamper the growth of the cardiac prosthetic devices market.

At the regional level, North America was the largest market in 2012 for cardiac prosthetic devices market followed by the European region. Cardiovascular diseases such as valvular and rheumatic diseases have increased significantly in the developed nations. Furthermore, a rise in life expectancy of the population has increased the frequency of degenerative valve diseases. Hence, with the rise in prevalence of these diseases, demand for cardiac prosthetic devices is expected to increase during the forecast period. Asia-Pacific region is expected to grow at a higher CAGR of 10.9% from 2013 to 2019. This is majorly due to large and expanding population base, increased participation of the respective governments in healthcare sector and rising disposable incomes of the population.

The cardiac prosthetic devices market is characterized by the presence of well-established players operating in this market. The major companies competing in this market are Edwards Lifesciences Corporation, Medtronic, Inc., Sorin Group, St. Jude Medical and Boston Scientific Corporation.

The global cardiac prosthetic devices market is segmented as follows:

Cardiac Prosthetic DevicesMarket, by Segments

Heart Valves

- Mechanical Heart Valves

- Tissue Heart Valves

- Transcatheter Heart Valves

Pacemaker

- Implantable Pacemaker

- External Pacemaker

Cardiac Prosthetic Devices Market, by Geography

- North America

- Europe

- Asia-Pacific

- Rest of the World (RoW)

 

Browse more reports: Transparency Market Research

Geotextiles and Geogrids Market in UAE and GCC - Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Transparency Market Research is Published new Market Report Geotextiles and Geogrids Market in UAE and GCC - Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019” the GCC (excluding UAE) geogrids market was valued at USD 83.3 million in 2012 and is expected to reach USD 182.5 million by 2019, growing at a CAGR of 11.6% from 2013 to 2019. In terms of volume, the demand was 24.5 million square meters in 2012 and is expected to reach 41.5 million square meters by 2019, growing at a CAGR of 7.7% from 2013 to 2019. The UAE geogrids market was valued at USD 15.1 million in 2012 and is expected to reach USD 32.9 million by 2019, growing at a CAGR of 11.8% from 2013 to 2019. In terms of volume, the demand was 4.2 million square meters in 2012 and is expected to be 7.0 million square meters by 2019, growing at a CAGR of 7.5% from 2013 to 2019.

The GCC (excluding UAE) geotextile market was valued at USD 101.2 million in 2012 and is expected to be USD 200.5 million by 2019, growing at a CAGR of 10.3% from 2013 to 2019. In terms of volume, the demand was 52.0 million square meters in 2012 and is expected to be 86.8 million square meters by 2019, growing at a CAGR of 7.6% from 2013 to 2019. The UAE geotextile market was valued at USD 27.8 million in 2012 and is expected to be USD 52.2 million by 2019, growing at a CAGR of 9.4% from 2013 to 2019. In terms of volume, the market was 13.5 million square meters in 2012 and is expected to be 22.0 million square meters by 2019, growing at a CAGR of 7.3% from 2013 to 2019.

Geogrids and geotextiles are often used together to perform various functions, such as soil reinforcement, separation, drainage, filtration and protection. Implementation of the mega-project, 'Gulf Railway' which is to connect all the countries present in the Gulf Cooperation Council by 2017, is expected to be one of the primary factors driving the demand for geotextiles and geogrids. In addition, gigantic road development projects are expected to play a significant role in the growth of the market within the forecast period, due to the sandy terrain of the region and focus of the various governments on infrastructural development. However, fluctuating costs of key raw materials, such as polypropylene and polyester on account of depleting petroleum reserves is expected to hamper the growth of the market over the next few years. Rising consumer awareness regarding advantages of natural geotextiles is expected to open new opportunities for the growth of the market over the next few years.

Nonwovens were the largest product type within the geotextile market segment and accounted for over 65% of the market share in 2012 due to its extensive use in drainage sub-systems and road construction. Increasing infrastructural activities in GCC countries, particularly road and drainage systems, is expected to drive the demand for nonwoven geotextiles over the next few years. It is expected to witness the fastest growth in this region within the forecast period.

Road construction and erosion control were the largest application segments of geotextiles in GCC (including UAE), accounting for over 60% of the market share in 2012. Erosion control is expected to be the fastest growing segment within the forecast period on account of growing infrastructure development such as roads, drainage systems and commercial and non-commercial construction. Demand for geotextiles in erosion control in UAE is expected to grow at a CAGR of 7.9% from 2013 to 2019.

Within the geogrids market segment, roadways were the largest application segment in 2012 in GCC and UAE. Geogrids are also being increasingly used in landscaping as they help in soil reinforcement. Road construction and landscaping are expected to witness the fastest growth over the next few years on account of increased construction activities such as expansion of airports, residential restructuring and development of commercial complexes. Demand for geogrids for application landscaping in GCC (excluding UAE) is expected to be 10,910.6 thousand square meters by 2019.

The report gives a comprehensive view of the geotextiles and geogrids market in terms of volume and revenue for GCC (excluding UAE) and UAE. The report comprises of the following segments:

Geotextiles Market: Product Segment Analysis

  • Nonwoven
  • Woven
  • Knitted

Geotextiles Market: Application Analysis

  • Road construction
  • Drainage
  • Erosion control
  • Others (Landfills)

Geogrids Market: Application Analysis

 

  • Roadways
  • Landscaping
  • Others

Browse more reports: Transparency Market Research

Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research

 

                                     f:id:tmrreport:20140207151143j:plain

According to a new market report published by Transparency Market Research "Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"in 2012, the global intravenous access devices market was valued at USD 27.2 billion and is expected to grow at a CAGR of 7.8% during the forecast period of 2013 to 2019  to reach a market value of USD 46.5 billion by 2019.

Intravenous (IV) access devices are utilized extensively for the delivery of almost every class of drugs such as analgesics, antibiotics and antipyretics. The IV access devices include IV needles, IV catheters and IV infusion pumps. The market for IV access devices will increase tremendously at the growing rate of 7.8% during the forecast period 2013 to 2019 with the increasing incidences of various diseases such as cancer and tuberculosis (TB).Increasing geriatric population worldwide will also support the growth of this market because elderly people are highly susceptible to aforementioned diseases. In addition, shifting trend towards home healthcare will further propel the growth of infusion pumps and catheters market which will also support the overall growth of the market.

Likewise, increase in number of surgeries throughout the globe will also trigger the growth of this market since; surgeries will require these access devices for various purposes such as medication and anesthetic. For instance, in 2012around 51.4 surgeries were reported according to the Centers for Disease Control and Prevention (CDC) in the U.S. and this number is expected to increase owing to various reasons such as increase in number of accidents and lifestyle. Similarly, increase in number of vaccines will also augment the growth of this market since administration of majority of the vaccines will utilize intravenous needles.The market for intravenous catheters is expected to grow at the highest CAGR of 9% during the forecast period 2013 to 2019. This growth is attributed to its wide application areas such as it is utilized when infusion pump is implanted in the body. Similarly, price competitiveness of the catheters will also support the growth of this market tremendously.

The North American region accounted for the largest share by revenue for intravenous access devices in the year 2012 owing to large number of patient pool and geriatric population. However, Asia-Pacific is expected to show the highest growth rate of 9.4% from 2013 to 2019. This is attributed to rise in geriatric population, target diseases, increase in healthcare expenditure and improving healthcare infrastructure in the Asia-Pacific region. In addition, rise in disposable income due to economic development will also propel the growth of the market in the region since it will increase the purchasing power of individuals for various medical services such as surgeries.

The major players operating in the market include Hospira, Inc., Becton, Dickinson and Company, CareFusion Corporation, Baxter International, B. Braun Melsungen AG and Smiths Medical.

The global intravenous access devices market has been segmented as below:

Intravenous Access Devices Market, by Product Types

  • Intravenous Needles
  • Intravenous Catheters
  • Midline Peripheral Catheter
  • Central Catheters
  • Midline Peripheral Catheters
  • Centrally Inserted Catheters
  • Intravenous Infusion Pumps
  • Intravenous Insulin infusion Pumps
  • Parenteral Feeding Infusion Pumps
  • Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps
  • Intravenous Syringe Infusion Pumps

Intravenous Access Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse more reports: Transparency Market Research

 

Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research

f:id:tmrreport:20140206210144j:plain

According to a new market report published by Transparency Market Research "Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"in 2012, the global intravenous access devices market was valued at USD 27.2 billion and is expected to grow at a CAGR of 7.8% during the forecast period of 2013 to 2019  to reach a market value of USD 46.5 billion by 2019.

Intravenous (IV) access devices are utilized extensively for the delivery of almost every class of drugs such as analgesics, antibiotics and antipyretics. The IV access devices include IV needles, IV catheters and IV infusion pumps. The market for IV access devices will increase tremendously at the growing rate of 7.8% during the forecast period 2013 to 2019 with the increasing incidences of various diseases such as cancer and tuberculosis (TB).Increasing geriatric population worldwide will also support the growth of this market because elderly people are highly susceptible to aforementioned diseases. In addition, shifting trend towards home healthcare will further propel the growth of infusion pumps and catheters market which will also support the overall growth of the market.

Likewise, increase in number of surgeries throughout the globe will also trigger the growth of this market since; surgeries will require these access devices for various purposes such as medication and anesthetic. For instance, in 2012around 51.4 surgeries were reported according to the Centers for Disease Control and Prevention (CDC) in the U.S. and this number is expected to increase owing to various reasons such as increase in number of accidents and lifestyle. Similarly, increase in number of vaccines will also augment the growth of this market since administration of majority of the vaccines will utilize intravenous needles.The market for intravenous catheters is expected to grow at the highest CAGR of 9% during the forecast period 2013 to 2019. This growth is attributed to its wide application areas such as it is utilized when infusion pump is implanted in the body. Similarly, price competitiveness of the catheters will also support the growth of this market tremendously.

The North American region accounted for the largest share by revenue for intravenous access devices in the year 2012 owing to large number of patient pool and geriatric population. However, Asia-Pacific is expected to show the highest growth rate of 9.4% from 2013 to 2019. This is attributed to rise in geriatric population, target diseases, increase in healthcare expenditure and improving healthcare infrastructure in the Asia-Pacific region. In addition, rise in disposable income due to economic development will also propel the growth of the market in the region since it will increase the purchasing power of individuals for various medical services such as surgeries.

The major players operating in the market include Hospira, Inc., Becton, Dickinson and Company, CareFusion Corporation, Baxter International, B. Braun Melsungen AG and Smiths Medical.

The global intravenous access devices market has been segmented as below:

Intravenous Access Devices Market, by Product Types

  • Intravenous Needles
  • Intravenous Catheters
  • Midline Peripheral Catheter
  • Central Catheters
  • Midline Peripheral Catheters
  • Centrally Inserted Catheters
  • Intravenous Infusion Pumps
  • Intravenous Insulin infusion Pumps
  • Parenteral Feeding Infusion Pumps
  • Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps
  • Intravenous Syringe Infusion Pumps

Intravenous Access Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse more reports: Transparency Market Research

Lithium Ion Battery Market is Expected to Reach USD 33.11 Billion in 2019: Transparency Market Research

f:id:tmrreport:20100526121528j:plain

According to a new market report published by Transparency Market Research "Global Lithium Ion Battery Market (Cathode, Anode, and Electrolytic solution) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013- 2019", the global market was worth USD 11.70 billion in 2012 and is expected to reach USD 33.11 billion in 2019, growing at a CAGR of 14.4% from 2013 to 2019. Due to the increasing demand and huge potential of lithium-ion battery in consumer, automotive and industrial sectors, Asia Pacific was the largest market for lithium-ion batteries in 2012.

The lithium-ion battery market is primarily driven by improving efficiency of battery and increasing application in EVs and HEVs and energy, medical and military. In addition, stringent government regulations related to carbon emissions in regions such as Europe, North America and China is supporting its growth. At the same time, higher life cycle as compared to lead nickel, nickel cadmium and nickel metal hydride batteries is expected to increase L-I demand in the coming years. High price as compared to other batteries and the risk of overheating are the factors inhibiting lithium-ion battery growth globally. However, the price is coming down and will have a positive impact on the market in the coming years.

Among different application sectors, the consumer sector is the largest followed by automotive in 2012, and is expected to maintain its position throughout the estimated period. Growing adoption of these batteries in consumer electronic products such as digital cameras, cellphones and tablet PCs is expected to fuel its growth in the estimated period.

Energy, medical and military sectors are the emerging sectors for lithium-ion battery offering huge potential in the coming years. Geographically, Asia Pacific holds the largest share in the lithium-ion battery market and accounted for 49.0% of the market in 2012. Japan and China are the major countries supporting the growth in this region. Japan is the leading manufacturer of lithium ion batteries globally. The manufacturers in these countries are focused to increase their sales in various regions. In addition, increasing adoption of HEVs in China is expected to fuel the growth in this region. Nevertheless, North America is expected to see the fastest growth, i.e., 15.5%, as it has been a pioneer in the adoption of the lithium-ion battery.

Automotive Energy Supply Corporation (AESC), A123 Systems LLC, GA Yuasa Corporation, Hitachi Chemical Co. Ltd., Johnson Controls, Inc., LG Chem Power, Inc., Panasonic Corporation, Samsung SDI Co. Ltd., Toshiba Corporation and China BAK Battery, Inc. are the popular players in the lithium-ion battery market. AESC holds major revenue share in 2012. The number of players in the lithium-ion battery market has increased in the last few years and more number of players is expected to enter this market in the coming years. However, global players are likely to collaborate with local players in order to expand their market in different regions.

Lithium-ion battery demand is expected to see a robust growth in the forecast period. This is due to its increasing demand across various application sectors such as automotive, wind, electronics, industrial and military. The market is currently driven by its usage in automotive sector in HEVs, trains and trams. Lithium-ion batteries can be differentiated primarily based on their functionality. The application of lithium-ion battery alongside other batteries is expected to increase, and lithium-ion batteries are expected to emerge as a replacement for lead acid batteries in the coming years.

This report has been segmented by material type, by application and by geography. It also includes the drivers, restraints and opportunities (DROs), Porter’s five forces analysis and value chain of the lithium-ion battery market. The study highlights current market trends and provides the forecast from 2013 to 2019.

 

Lithium-Ion Battery Market by Material Type

      ·         Cathode

·         Anode

·         Electrolytic Solution

·         Others (Binders, Separators etc)

 

Lithium-Ion Battery Market by Application

·         Automotive

·         Cars

·         Bus and Trucks

·         Train and Airplanes

·         Other (e-scooter and e-bikes)

·         Industrial

·         Cranes

·         Valves

·         Mining

·         Smart Grid

·         Consumer

·         Mobile phones, smartphones and tablet PCs

·         UPS

·         Others

·         Others (Energy, Medical, Military)

 

Lithium-Ion Battery Market by Geography

·         North America

·         Europe

·         Asia-Pacific

·         Rest of the World

 

Browse more Reports: Transparency Market Research